| P2093 | author name string | Beverley D Glass | |
| P2860 | cites work | Counterfeit and substandard antimalarial drugs in Cambodia | Q21032487 |
| | Malaria in the Greater Mekong Subregion: heterogeneity and complexity | Q21032492 |
| | Fatal renal failure caused by diethylene glycol in paracetamol elixir: the Bangladesh epidemic | Q24645539 |
| | Does price reveal poor-quality drugs? Evidence from 17 countries | Q30051564 |
| | Safeguarding against substandard/counterfeit drugs: mitigating a macroeconomic pandemic. | Q30375560 |
| | Direct measurement of microkeratome gap width by electron microscopy | Q30992990 |
| | Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries | Q33542424 |
| | Counterfeit drugs detection by measurement of tablets and secondary packaging colour | Q33603883 |
| | Increase in catheter insertion-site infections associated to the introduction of a substandard competitive antiseptic. | Q51153952 |
| | Near-infrared spectroscopy (NIRS) and chemometric analysis of Malaysian and UK paracetamol tablets: a spectral database study. | Q51560885 |
| | Expiry-date tampering | Q56875744 |
| | A counterfeit drug treaty: great idea, wrong implementation | Q82238541 |
| | Counterfeit drugs: a growing global threat | Q83511309 |
| | Pharmaceutical quality: an urgent and unresolved issue | Q84220705 |
| | Are counterfeit or substandard anti-infective products the cause of treatment failure in Papua New Guinea? | Q84484719 |
| | Poor-quality medical products: time to address substandards, not only counterfeits | Q84836315 |
| | Impact of poor-quality medicines in the 'developing' world | Q33754271 |
| | Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa. | Q34277322 |
| | Improving global health governance to combat counterfeit medicines: a proposal for a UNODC-WHO-Interpol trilateral mechanism | Q34478121 |
| | Counterfeit anti-infective drugs | Q34560327 |
| | Reforms: a quest for efficiency or an opportunity for vested interests'? A case study of pharmaceutical policy reforms in Tanzania | Q34815820 |
| | A systematic overview of published antimalarial drug trials | Q35667922 |
| | The accuracy of self monitoring blood glucose meter systems in Kampala Uganda | Q36276240 |
| | Laboratory medicine in Africa: a barrier to effective health care | Q36360150 |
| | Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence | Q36841156 |
| | Substandard and counterfeit medicines: a systematic review of the literature | Q37117268 |
| | Drug-resistant tuberculosis in the European Union: opportunities and challenges for control | Q37728731 |
| | Supply and use of essential drugs in sub-Saharan Africa: some issues and possible solutions | Q37777918 |
| | Update on counterfeit antibiotics worldwide; public health risks | Q38012546 |
| | Understanding and fighting the medicine counterfeit market | Q38079305 |
| | Medicines counterfeiting is a complex problem: a review of key challenges across the supply chain | Q38105156 |
| | Assessing the impact of substandard copy medicines in developing countries: the experience with imatinib copies | Q38154622 |
| | Comparison of two amoxicillin/clavulanic acid-resistant profiles employing two types of assay disks: A pilot study in 50 isolates from a tertiary care hospital in India | Q38515568 |
| | Quality of medical devices and in vitro diagnostics in resource-limited settings | Q39269027 |
| | Evaluation of the residual solvent content of counterfeit tablets and capsules. | Q39428025 |
| | Assessment of the incidence of substandard drugs in developing countries | Q41927764 |
| | Use of refractometry and colorimetry as field methods to rapidly assess antimalarial drug quality | Q41944698 |
| | Development and validation of a reversed-phase LC method for analysing potentially counterfeit antimalarial medicines | Q41945774 |
| | Murder by fake drugs | Q42776939 |
| | Reliable low-cost capillary electrophoresis device for drug quality control and counterfeit medicines | Q42933835 |
| | US Pharmacopeia fighting counterfeit medicines in Africa | Q42962621 |
| | Counterfeit praziquantel. | Q43729546 |
| | Counterfeit artesunate antimalarials in southeast Asia | Q44515897 |
| | Evaluating the performance of basic fuchsin for the Ziehl-Neelsen stain. | Q46184848 |
| | Detecting counterfeit antimalarial tablets by near-infrared spectroscopy | Q46429483 |
| | Assessment of hand-held Raman instrumentation for in situ screening for potentially counterfeit artesunate antimalarial tablets by FT-Raman spectroscopy and direct ionization mass spectrometry | Q46487883 |
| | Antidepressants are sold as antiretrovirals in DR Congo | Q46534663 |
| | Establishment of a Fast Chemical Identification System for screening of counterfeit drugs of macrolide antibiotics | Q46640560 |
| | An LC method for the simultaneous screening of some common counterfeit and sub-standard antibiotics Validation and uncertainty estimation | Q46775890 |
| | Evaluation of oxacillin and cefoxitin disks for detection of resistance in coagulase negative staphylococci. | Q46960161 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | medical device | Q6554101 |
| P304 | page(s) | 11-22 | |
| P577 | publication date | 2014-04-24 | |
| P1433 | published in | Research and Reports in Tropical Medicine | Q15817521 |
| P1476 | title | Counterfeit drugs and medical devices in developing countries | |
| P478 | volume | 5 | |